Latest News
-

AMT-130 at Four Years: Hopeful Signs, Complex Controls
12 min read
uniQure reports that after 4 years, people given high-dose AMT-130 continue to show signs of slower HD progression, providing hope for their recent regulatory submission. But the new analyses are nuanced. We unpack the hopeful, but complex results.
-

Calming down the immune system helps Huntington's disease mice
10 min read
CB2-activating drug improves survival and symptoms in Huntington's disease mice through calming down the immune syste
-

Of mice and men: using animal models to study Huntington's disease
8 min read
Animal models of Huntington's disease: what they tell us about the disease and how can they help develop new therapie
-

HDBuzz Prize runner-up 2012: Fruit flies, faulty connections and Huntington's disease
5 min read
Recent study in fruit flies identifies a new connection between synapses and HD
-

Illuminating findings in blood cells from Huntington's disease patients
7 min read
Levels of the huntingtin protein can be directly measured in blood – could this be useful for gene silencing studies?
-

Giving Huntington's disease the finger? Two teams report success for zinc-finger drugs in cells and mice
9 min read
Success in Huntington’s disease cells and mice for zinc finger drugs that reduce production of the harmful protein
-

Start here!
5 min read
Huntington's disease research news. In plain language. Written by scientists. For the global HD community.
-

HDBuzz Prize winner 2012: Deep brain stimulation for HD
7 min read
HDBuzz Prizewinner 2012: Deep brain stimulation to treat uncontrollable movements called chorea in Huntington's disea
-

Interview: Alice and Nancy Wexler
10 min read
HDBuzz interviews Alice and Nancy Wexler, the sisters at the heart of the Hereditary Disease Foundation
-

Video: What’s new in Huntington's disease research 2012
35 min read
Watch Ed Wild's address to the European Huntington's Association on how HD research works and the most promising poss

